ORENTI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 5.949
EU - Europa 5.461
AS - Asia 5.172
Continente sconosciuto - Info sul continente non disponibili 792
SA - Sud America 489
AF - Africa 156
OC - Oceania 52
Totale 18.071
Nazione #
US - Stati Uniti d'America 5.623
IT - Italia 1.876
SG - Singapore 1.532
CN - Cina 1.397
GB - Regno Unito 1.115
BD - Bangladesh 571
DE - Germania 458
HK - Hong Kong 447
FR - Francia 374
BR - Brasile 362
VN - Vietnam 361
RU - Federazione Russa 353
SE - Svezia 335
IN - India 246
CA - Canada 237
IE - Irlanda 179
NL - Olanda 154
FI - Finlandia 149
ID - Indonesia 105
JP - Giappone 98
KR - Corea 87
DK - Danimarca 85
ES - Italia 75
BE - Belgio 53
TR - Turchia 53
AU - Australia 48
CH - Svizzera 40
ZA - Sudafrica 39
AR - Argentina 35
AT - Austria 35
PK - Pakistan 35
IQ - Iraq 33
MX - Messico 33
UA - Ucraina 30
PL - Polonia 29
PH - Filippine 26
UG - Uganda 25
CI - Costa d'Avorio 24
UZ - Uzbekistan 24
CO - Colombia 20
EC - Ecuador 20
MY - Malesia 19
EG - Egitto 18
PT - Portogallo 18
SA - Arabia Saudita 18
IL - Israele 17
TW - Taiwan 16
CZ - Repubblica Ceca 15
MA - Marocco 15
PE - Perù 15
HU - Ungheria 13
NP - Nepal 13
TH - Thailandia 12
CL - Cile 11
TN - Tunisia 11
GR - Grecia 10
IR - Iran 9
JM - Giamaica 9
UY - Uruguay 9
VE - Venezuela 9
CR - Costa Rica 8
LU - Lussemburgo 8
SI - Slovenia 8
TT - Trinidad e Tobago 8
EU - Europa 7
LB - Libano 7
LT - Lituania 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
HN - Honduras 6
JO - Giordania 6
XK - ???statistics.table.value.countryCode.XK??? 6
DZ - Algeria 5
GE - Georgia 5
GT - Guatemala 5
KE - Kenya 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
NI - Nicaragua 4
NO - Norvegia 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
AZ - Azerbaigian 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
LV - Lettonia 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
KH - Cambogia 2
Totale 17.260
Città #
Singapore 846
Southend 808
Ashburn 692
Milan 522
Hong Kong 400
San Jose 361
Chandler 354
Council Bluffs 323
Dallas 299
Beijing 236
Santa Clara 209
Los Angeles 193
Fairfield 174
Princeton 158
Dublin 157
Wilmington 155
Boardman 149
Frankfurt am Main 147
Seattle 143
Rome 136
New York 135
Ho Chi Minh City 116
Houston 115
Ann Arbor 104
Toronto 102
Hefei 99
Buffalo 94
Lauterbourg 93
Woodbridge 88
Helsinki 85
Dearborn 78
Bengaluru 77
Jakarta 74
Hanoi 73
Moscow 72
Guangzhou 69
Des Moines 66
Cambridge 62
Nanjing 53
Tokyo 48
Shanghai 46
São Paulo 42
Naples 39
Seoul 38
Hanover 36
Munich 35
Redwood City 35
Phoenix 34
Amsterdam 33
Cangzhou 33
Chicago 33
Columbus 32
Ottawa 32
Tianjin 32
Jinan 31
Bologna 29
Mountain View 26
The Dalles 26
Abidjan 24
Paris 24
Redmond 24
Birmingham 23
Kampala 23
Madrid 23
Nuremberg 23
Shenyang 23
Fuzhou 22
Hangzhou 22
London 22
Berlin 21
Lappeenranta 21
Shenzhen 21
Turin 20
Changsha 19
Florence 19
Catania 18
Hebei 18
Zhengzhou 18
Bari 17
Brussels 17
Dong Ket 17
Palermo 17
Pune 17
San Diego 17
Genoa 16
Verona 16
Atlanta 15
Boston 15
Brooklyn 15
Cardiff 15
Cordova 15
Da Nang 15
Falls Church 15
Haiphong 15
Lima 15
Orem 15
Dhaka 14
Heidelberg 14
North Bergen 14
Brescia 13
Totale 9.544
Nome #
Valutazione delle dimissioni pianificate: Concordanza tra indice di BRASS e giudizio clinic [The assessment of planned discharges: agreement between BRASS index and clinical judgement] 893
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry Cohort study 481
Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation : the IDEA Study 392
Genetic Polymorphisms of Functional Candidate Genes and Recurrent Acute Otitis Media With or Without Tympanic Membrane Perforation 363
SURVIVAL ANALYSIS AND REGRESSION MODELS IN THE PRESENCE OF COMPETING AND SEMI-COMPETING RISKS 357
Pneumococcal colonization in older adults 352
Epidemiology of European adults with cystic fibrosis 346
Distribution of cystic fibrosis patients not eligible to studied CFTR modulators in Europe 312
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy 269
Fever and pain management in childhood : Healthcare providers’ and parents’ adherence to current recommendations 255
Autoimmunity and cytokine imbalance in inherited epidermolysis bullosa 254
Pinpointing outliers in experimental data: the Hat matrix in Anova for fixed and mixed effects models 249
Genetic polymorphisms and the development of invasive bacterial infections in children 249
Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients 242
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study 239
CHANGES IN FEV1 PERCENT OF PREDICTED OF PEOPLE WITH CYSTIC FIBROSIS IN THE LAST DECADE: USE OF DIFFERENT STATISTICAL METHODS 237
Nasal spray live attenuated influenza vaccine : the first experience in Italy in children and adolescents during the 2020–21 season 236
Hospital discharge : testing the "Blaylock Risk Assessment Screening Score" in a surgical department 233
10-years changes in lung function of cystic fibrosis patients in Europe: different statistical methods at work 231
Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian study 224
The European Cystic Fibrosis Society Patient Registry (ECFSPR) data validation programme: accuracy and consistency of data 209
Differential benefit of docetaxel-based chemotherapy in breast cancer patients according to baseline body mass index 206
Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy 202
Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis : A pragmatic non-randomized trial 200
Estimate cause specific survival in soft tissue retroperitoneal sarcomas in the presence of competing risks : relative and net survival 196
Estimating Relapse Free Survival as a Net Probability : Regression Models and Graphical Representation : An Application of a Large Breast Cancer Case Series 189
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe 186
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era 185
Detecting outliers and/or leverage points : a robust two-stage procedure with bootstrap cut-off points 184
The burden of air pollution and temperature on Raynaud’s phenomenon secondary to systemic sclerosis 181
A MULTI-STATE MODEL EVALUATING THE ASSOCIATION OF OXYGEN THERAPY WITH THE COURSE OF CYSTIC FIBROSIS IN EUROPE 178
Uniphasic blanching of the fingers, abnormal capillaroscopy in nonsymptomatic digits, and autoantibodies: expanding options to increase the level of suspicion of connective tissue diseases beyond the classification of Raynaud's Phenomenon 177
Antibody response to respiratory syncytial virus infection in children <18 months old 175
Evolution of disease in people with cystic fibrosis carrying 2 nonsense mutations in Europe 172
Comorbidity burden conditions the prognostic performance of D-dimer in elderly patients with acute pulmonary embolism 171
Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation 169
Performance of robust regression methods in real-time polymerase chain reaction calibration 166
Survival functions in the presence of several events and competing risks : estimation and interpretation Beyond Kaplan-Meier 162
Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage 162
Presenza di outlier nei saggi biologici con PCR real-time: L1-norm (LAD) or L2-norm (OLS)? 161
Enhanced liver fibrosis test : a further step toward depiction of fibrotic process in very early diagnosis of systemic sclerosis 160
The European Cystic Fibrosis Society Patient Registry’s Data Quality programme 160
Robust Regression as a Sensible Alternative to the Weighted Ordinary Least Squares Regression in case of Heteroskedasticity. A Tutorial 159
Fisiobrì : valutazione del supporto fisioterapico domiciliare alla terapia antibiotica con colistimetato sodico 159
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 158
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study 155
Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a single centre pragmatic non-randomised trial 155
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry 155
Empirical Approach to Investigate Raynaud's Phenomenon : the Pearl Study : AB1085  154
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 153
Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy 150
Trauma e discontinuità temporale nei minori vittime di disastri naturali : Il Test de trois dessins : Avant, pendant et avenir 148
Acute effect of iloprost on peripheral circulation as assessed by videocapillaroscopy and 22-mhz power doppler ultrasonography 148
Short and long-term mortality in elderly patients with suspected not confirmed pulmonary embolism 148
The parameter τ and its role in least absolute deviation regression 147
Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients 147
Prognostic value of D-dimer in elderly patients with Pulmonary Embolism 147
From ordinary to generalized least squares : a worked example 145
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry 144
A pseudo-values regression model for non-fatal event free survival in the presence of semi-competing risks 144
Factors associated with sustained Pseudomonas aeruginosa infection following elexacaftor/tezacaftor/ivacaftor treatment: Real-world data from the European cystic fibrosis society patient registry 143
Lung transplantation and mortality in patients with cystic fibrosis under oxygen therapy 143
Fibrosis biomarkers in isolated Raynaud's phenomenon : too little, too soon? 141
How early starts increased collagen synthesis in systemic sclerosis? 141
Pinpointing outliers and influential cases in regression analysis : a robust method at work 137
Cystic fibrosis in Europe: improved lung function & longevity: reasons for cautious optimism, but challenges remain 137
Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients : 15-Year results of trial and out-trial patients 136
Enhanced liver fibrosis test: a further step toward depiction of fibrotic process in very early diagnosis of systemic sclerosis 132
Performance of robust regression methods in real-time polymerase chain reaction calibration 131
Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation 127
A performance counterexample of Billor-Chatterjee-Hadi procedure and an improvement proposal for robust regression 125
Epidemiology of European adults with Cystic Fibrosis 125
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysis 124
Robust regression analysis : a useful two stage procedure 124
Incidence of SARS-CoV-2 and risk factors for severe outcomes in people with cystic fibrosis in Europe 119
Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis 119
Total ankle replacement: is pre-operative varus deformity a predictor of poor survival rate and clinical and radiological outcomes? 119
History of digital ulcers in patients with systemic sclerosis is associated with peripheral vasculopathy as assessed by videocapillaroscopy and 22-mhz power doppler ultrasonography 113
Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalization for non-critical COVID-19 113
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry 109
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA 107
Predictors of medium- and long-term mortality in elderly patients with acute pulmonary embolism 107
Pseudo-values regression models in the presence of semi-competing risks 106
Pianificare la dimissione dei soggetti adulti ricoverati nel dipartimento chirurgico: uno studio osservazionale 105
Global prevalence of CFTR variants with respect to their responsiveness to elexacaftor-tezacaftor-ivacaftor 104
Comorbidity assessment as predictor of short and long-term mortality in elderly patients with hemodynamically stable acute pulmonary embolism 104
How much temperature can truly impact on Raynaud’s phenomenon secondary to systemic sclerosis? 103
Home physiotherapists assisting follow-up treatment in cystic fibrosis : a multicenter observational study 103
A reaction to a challenging example in multiple regression analysis 102
Variability in Disease Severity Among Cystic Fibrosis Patients carrying Residual Function Variants: Data from the European Cystic Fibrosis Society Patient Registry 102
Comorbidities and prognostic performance of D-Dimer in acute pulmonary embolism elderly patients 101
Methicillin-Resistant Staphylococcus Aureus and Pulmonary Outcome in People with Cystic Fibrosis: A European Cystic Fibrosis Patient Registry Data Analysis 100
Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patients 98
How much temperature can truly impact on raynaud's phenomenon secondary to systemic sclerosis? 98
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management 98
Esimating relapse free survival as a net probability: regression models and graphical representation 97
Regression models in the presence of semi-competing risks 93
Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry 88
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children 85
Sustaining adherence to colistimethate sodium (Colobreathe®) through a physiotherapist-supervised program (PsP) at home 85
Totale 17.625
Categoria #
all - tutte 53.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.319 0 84 63 87 102 135 104 82 200 107 112 243
2022/20231.531 182 138 152 160 138 256 47 117 164 29 105 43
2023/20241.477 55 65 107 127 273 148 78 114 55 96 159 200
2024/20252.879 176 283 98 268 226 160 97 274 175 225 311 586
2025/20266.557 611 396 563 438 575 401 755 342 660 469 709 638
2026/2027863 458 405 0 0 0 0 0 0 0 0 0 0
Totale 18.071